Previously, umbilical cord blood stem cells were good for children but now this is safe and effective for adults with blood cancers.
They grew more umbilical cord blood stem cells outside the body then transplanted it into an adult blood cancer patients. They were able to restore a normal of blood cells.
Immune therapy company Gamida Cell produces this umbilical cord blood stem cell treatment known as NiCord, and after more successful trials plan to seek approval from the FDA.
They shorten the time that adult blood cancer patients have a compromised immune system down to 11.5 days.
94 percent of adult patients with blood cancers who received the umbilical cord blood treatment ended up with successful graft procedures within six weeks.
Journal of Clinical Oncology – Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.